Data Characteristics
Bioequivalence (BE) study regulations and SOP documents typically originate from guidelines, technical requirements, and regulatory files published by drug regulatory agencies (e.g., NMPA, FDA, EMA). Internal standard operating procedures also serve as sources. These documents have a relatively stable update frequency, usually revised annually or updated periodically based on new scientific discoveries and technological advancements. Document structures are rigorous, often in PDF format, containing extensive specialized terminology, charts, formulas, and references. Content covers various aspects, including trial design, subject selection, sample analysis, and statistical evaluation. Key fields include active pharmaceutical ingredient, dosage form, administration route, study protocol number, version number, revision date, effective date, and critical parameters such as Cmax, AUC, Tmax, and their confidence intervals. Units commonly involve concentration (ng/mL), time (h), and area (ng·h/mL).
Constraints on "Reference Tracing and Source Attribution"
The rigor and specificity of bioequivalence regulatory documents impose high demands on reference tracing and source attribution. First, document update frequency is low, but any revision can impact compliance judgments. Therefore, quoted regulatory versions must be current and effective. Second, charts and formulas in documents are critical information. RAG models require special handling during text chunking to prevent fragmentation or omission of chart content, which affects semantic integrity. Third, extensive specialized terminology and abbreviations require the knowledge base to have strong semantic understanding capabilities for accurate identification and association. Finally, precise traceability to specific paragraphs or page numbers in original documents is crucial. This meets compliance requirements and provides a basis for engineers to conduct secondary verification, preventing misjudgments due to ambiguous references.
Configuration Settings
| Configuration Item | Recommended Setting | Rationale |
|---|---|---|
Chunk size (Chunk Length) | 800–1200 characters | Preserves the integrity of logical paragraphs in bioequivalence regulations, reducing semantic fragmentation. |
Recall count (Recall Count) | Top 8 | Ensures coverage of sufficient relevant regulatory clauses, improving answer comprehensiveness. |
Similarity threshold (Similarity Threshold) | 0.75 | Filters out highly relevant regulatory text, avoiding interference from irrelevant information. |
Rerank result count (Rerank Return Count) | Top 5 | After reranking, prioritizes the most relevant regulatory paragraphs, enhancing user experience. |
maxContext | 4000 tokens | Accommodates longer clauses and related background information in bioequivalence regulations. |
Citation Content Template (Reference Content Template) | [${doc.sourceName}] ${doc.text} | Clearly displays the referenced document name and specific content for easy traceability. |
Common Pitfalls
- Issue: AI responses cite outdated regulatory clauses, leading to inaccurate compliance advice. Reason: The knowledge base failed to update to the latest version of regulatory documents, or the document index did not correctly identify version numbers.
- Issue: AI responses cite documents, but clicking the traceability link does not navigate to the exact page number in the original PDF. Reason: The
Citation Content Template(Reference Content Template) configuration does not include page number information, or page number metadata was not accurately extracted during document parsing. - Issue: When asked about statistical methods, the AI provides cited content that lacks critical formulas or charts, offering only textual descriptions. Reason: The document chunking strategy did not effectively process embedded charts and formulas, leading to the loss of this critical information during retrieval.
How to Verify Configuration
- Compare the regulatory clauses cited in AI responses with the latest effective official documents to verify version consistency.
- Randomly select multiple Q&A results and click the traceability links to check if they accurately navigate to the corresponding paragraph or page number in the original document.
- Test with complex questions involving charts and formulas to confirm if the AI response effectively cites and explains these non-textual elements.
- Evaluate questions with different specialized terminologies to check if the AI's cited content accurately understands the term's meaning and provides relevant regulatory explanations.
Note: The values given are common starting points and should be measured against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.